acrolein has been researched along with Hemorrhage in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albo, M; Chiang, G; Khimji, C; Lee, J; Lee, S; Malkmus, S; Yaksh, T | 1 |
| Chai, Y; Dai, M; Fan, Z; Huang, F; Huang, H; Jiang, Q; Li, X; Liu, Q; Lu, Y; Mai, Q; Meng, F; Shen, K; Sun, J; Wei, Q; Xu, D; Xu, N; Yu, G; Zhang, Y; Zhao, H; Zhou, D; Zhou, H; Zhou, Y | 1 |
| Bhatnagar, A; Conklin, DJ; Haberzettl, P; Lesgards, JF; Prough, RA; Srivastava, S | 1 |
| Liu, SH; Wang, CC; Weng, TI; Wu, ET; Wu, MH; Yang, RS | 1 |
| Batista, CK; Brito, GA; Cunha, FQ; Leitão, BT; Mota, JM; Ribeiro, RA; Souza, MH; Souza, ML | 1 |
| Batista, CK; Brito, GA; Cunha, FQ; Leitão, BT; Ribeiro, RA; Souza, ML | 1 |
| Korkmaz, A; Oter, S; Topal, T | 1 |
| Almeida, PR; Baltazar, F; Macedo, FY; Mota, JM; Mourão, LC; Ribeiro, RA; Schmitt, FC | 1 |
| Hader, JE; Jacobs, SC; Marzella, L; Myers, RA; Naslund, MJ | 1 |
| Cubeddu, LX; Malave, A; Xu, X | 1 |
1 review(s) available for acrolein and Hemorrhage
| Article | Year |
|---|---|
Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.
Topics: Acrolein; Antineoplastic Agents; Cell Death; Cyclophosphamide; Cystitis; Cytokines; DNA Damage; Enzyme Activation; Hemorrhage; Humans; Ifosfamide; Lipid Peroxidation; Mesna; Nitrogen; Oxygen; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Transcription Factors | 2007 |
1 trial(s) available for acrolein and Hemorrhage
| Article | Year |
|---|---|
Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine.
Topics: Acrolein; Adolescent; Adult; Aged; Allografts; Biotransformation; Child; Cyclophosphamide; Cystitis; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hemorrhage; Histocompatibility; Humans; Incidence; Infusions, Intravenous; Mesna; Middle Aged; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Transplantation Conditioning; Young Adult | 2015 |
8 other study(ies) available for acrolein and Hemorrhage
| Article | Year |
|---|---|
Repeated Low-Dose Acrolein Triggers Irreversible Lamina Propria Edema in Urinary Bladder, Transient Voiding Behavior and Widening of Eyes to Mechanical Stimuli.
Topics: Acrolein; Alkylating Agents; Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hemorrhage; Humans; Mice; Mucous Membrane; Muscle, Smooth; Urinary Bladder | 2021 |
Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.
Topics: Acetylcysteine; Acrolein; Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Cystitis; Glutathione Transferase; Hemorrhage; Immunohistochemistry; In Situ Nick-End Labeling; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder; Urinary Bladder Diseases | 2009 |
Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide.
Topics: Acrolein; Animals; Blotting, Western; Cyclophosphamide; Cystitis; Female; Hemorrhage; Immunohistochemistry; Interleukin-6; Muscle Contraction; Muscle, Smooth; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Urinary Bladder | 2013 |
Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
Topics: Acrolein; Amifostine; Animals; Antidotes; Antineoplastic Agents, Alkylating; Cystitis; Dose-Response Relationship, Drug; Edema; Glutathione; Hemorrhage; Ifosfamide; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Radiation-Protective Agents; Urinary Bladder | 2007 |
A model of hemorrhagic cystitis induced with acrolein in mice.
Topics: Acrolein; Animals; Cystitis; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hemorrhage; Male; Mesna; Mice; Protective Agents; Urinary Bladder | 2006 |
Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis.
Topics: Acrolein; Administration, Intravesical; Animals; Cyclooxygenase 2; Cystitis; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Hemorrhage; Male; Organ Size; Rats; Rats, Wistar; Time Factors; Urinary Bladder | 2008 |
Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis.
Topics: Acrolein; Animals; Cyclophosphamide; Cystitis; Female; Hemorrhage; Hyperbaric Oxygenation; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urinary Bladder Diseases | 1993 |
Expression of inducible nitric oxide synthase in primary culture of rat bladder smooth muscle cells by plasma from cyclophosphamide-treated rats.
Topics: Acrolein; Animals; Cells, Cultured; Cyclophosphamide; Cystitis; Dose-Response Relationship, Drug; Hemorrhage; Interferon-gamma; Isothiuronium; Male; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organ Size; Plasma; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Urinary Bladder | 2001 |